| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Traws Pharma, Inc. (TRAW) has 11 insiders with recent SEC Form 4 filings, including 1 buy and 0 sells. TRAW is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| 10% | 597.7K | $508.2K | - | |
| COO | 150.6K | $128.1K | - | |
| CEO | 147.8K | $125.6K | - | |
| Other | 116.0K | $98.6K | - | |
| Other | 113.9K | $96.9K | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Apr 26, 2017 | Bienen Henry S | Director | Buy | 3,810 | $2.10 | $8,001.00 | +42.7% |